Summary
Signal counts
Assets tracked: 5
Watchlist assets: 4
Registry stop assets: 0
Sponsor overview
RemeGen Co., .
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT06962865 | https://clinicaltrials.gov/study/NCT06038396 | https://clinicaltrials.gov/study/NCT05205850 | https://clinicaltrials.gov/study/NCT05980481 | https://clinicaltrials.gov/study/NCT06173037
Assets
Linked programs
- RC108: Low Signal (0/5)
- RC118: Watchlist Signal (2/5)
- RC118-ADC: Timeline Staleness Signal (4/5)
- RC48-ADC（2.5mg/kg）: Watchlist Signal (2/5)
- RC88: Results Not Found Signal (2/5)